Table 1.

Medication history overview (in- as well as outpatient periods).

Agent	Dose/s	Period	Comment
Haloperidol (HAL)	Up to 10 mg/d	2015 (4 mths) 2018 (1 mth) 2020 (2 wks)*	Combined with diazepam improved the most distressing hallucinations but caused intolerable extrapyramidal side effects (EPS).
Risperidone (RIS)	6 mg/d	2015–2016 (~1 year)	Partially relieved the positive symptoms despite suspected concomitant drug use, but caused EPS and ejaculatory dysfunction. It was replaced by Clozapine, and after a second attempt (4 mths in 2017 during a later admission event) by Quetiapine.
Olanzapine (OLA)	Up to 30 mg/d prn 7.5–15 mg during exacerbations	2018 (2 mths)	Good sedative effect and transiently improved hallucinations and delusions.
Clozapine	Up to 700 mg/d	2015–2018 (~3 yrs)	The most effective medication according to the medical staff. The patient reported asymptomatic periods alternating with periods of controllable symptoms, though never a permanent relief.
Quetiapine (QUE)	900 mg/d	Current	The most effective medication according to the patient, particularly against hallucinations and anxiety, but still without a permanent relief as monotherapy.
Aripiprazole	Up to 30 mg/d	2017 (3 wks, October)	The patient refused to continue with it and stated that “it was not good” for him, without further explanation.
Lithium	Up to 210 mg/d	2018 (October) - current	Used as a calming agent.

^*Discussed in the current report.